Skip to main content

FR
EN

Drupal

Main navigation EN

About Crossject
Our technology
Therapeutic areas

Main navigation 2 EN

Finances
News
- Our news
- Press releases
Careers
- Working at Crossject
- Available position and applications
Contact

Search

Enter the terms you wish to search for.

Home
Finances
Crossject announces significant improvement in Gaïa ESG rating

Crossject announces significant improvement in Gaïa ESG rating

Image

Date de parution

2023/09/11

PDF du document

Press release ESG_EN.pdf205.47 KB

FINANCES CONTACT

Natasha DRAPEAU

Last financial releases

Crossject reports financial results and business highlights for first half of 2023

2023/09/26

Crossject announces significant improvement in Gaïa ESG rating

2023/09/11

Crossject reports successful completion of European and U.S. audits for manufacturing of ZENEO® Midazolam for epileptic seizures

2023/09/05

Menu Pied de page

News
Legal information
Sitemap
Privacy Terms
Cookies

FOLLOW US